Prediction model for leaflet thrombosis in patients undergoing transcatheter aortic valve implantation: the EFFORT study
Clinical Research in Cardiology · 2025
DOI: 10.1007/s00392-024-02486-3 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical Research in Cardiology, 2025. Verfasst von Gloria M Steiner-Gager und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine II, Division of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Thrombosis, Aortic Valve Stenosis, Aortic Valve. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Medical University of Vienna.
Abstract (Originalsprache)
Background
Leaflet thrombosis (LT) is a multifaceted and underexplored condition that can manifest following transcatheter aortic valve implantation (TAVI). The objective of this study was to formulate a prediction model based on laboratory assessments and clinical parameters, providing additional guidance and insight into this relatively unexplored aspect of post-TAVI complications.
Methods
The present study was an observational prospective hypothesis-generating study, including 101 patients who underwent TAVI and a screening for LT (the primary endpoint) by multidetector computed tomography (MDCT). All images were acquired on a third-generation dual-source CT system. Levels of von Willebrand factor (vWF) activity, hemoglobin (Hb), and lactate dehydrogenase (LDH) were measured among other parameters. A predictive score utilizing binary logistic regression, Kaplan–Meier time-to-event analysis, and receiver operating characteristics (ROC) analysis was established.
Results
LT (11 subclinical and 2 clinical) was detected in 13 of 101 patients (13%) after a median time to screening by MDCT of 105 days (IQR, 98–129 days). Elevated levels of vWF activity (> 188%) pre-TAVI, decreased Hb values (< 11.9 g/dL), as well as increased levels of LDH (> 312 U/L) post-TAVI and absence of oral anticoagulation (OAC) were found in patients with subsequent LT formation as compared to patients without LT. The established EFFORT score ranged from − 1 to 3 points, with an increased probability for LT development in patients with ≥ 2 points (85.7% of LT cases) vs < 2 points (14.3% of LT cases; p < 0.001). Achieving an EFFORT score of ≥ 2 points was found to be significantly associated with a 10.8 times higher likelihood of developing an LT ( p = 0.001). The EFFORT score has an excellent c-statistic (area under the curve (AUC) = 0.89; 95% CI 0.74–1.00; p = 0.001) and a high negative predictive value (98%).
Conclusion
An EFFORT score might be a helpful tool to predict LT development and could be used in risk assessment, if validated in confirmatory studies. Therefore, the score has the potential to guide the stratification of individuals for the planning of subsequent MDCT screenings. Graphical abstract Central illustration. Created with BioRender.com
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine II, Division of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
- Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
- Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
- Department of Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
- Central Radiology Institute, Diagnostic and Interventional Radiology, Klinik Landstraße, Vienna, Austria.
- Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
Förderung
- Austrian Science Fund
- Medical University of Vienna
Zitieren
APA
Steiner-Gager, G. M., Rogozarski, J., Kronberger, C., Dizdarevic, A. M., Quehenberger, P., Schernthaner, R., Loewe, C., Reider, L., Strassl, A., Kovacevic Miljevic, K., Jilma, B., Ay, C., Königsbrügge, O., Postula, M., Hengstenberg, C., & Siller-Matula, J. M. (2025). Prediction model for leaflet thrombosis in patients undergoing transcatheter aortic valve implantation: the EFFORT study. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-024-02486-3
Vancouver
Steiner-Gager GM, Rogozarski J, Kronberger C, Dizdarevic AM, Quehenberger P, Schernthaner R, et al. Prediction model for leaflet thrombosis in patients undergoing transcatheter aortic valve implantation: the EFFORT study. Clinical Research in Cardiology. 2025. doi:10.1007/s00392-024-02486-3
BibTeX
@article{SteinerGager2025,
author = {Steiner-Gager, Gloria M and Rogozarski, Jovan and Kronberger, Christina and Dizdarevic, Al Medina and Quehenberger, Peter and Schernthaner, Ruediger and Loewe, Christian and Reider, Lukas and Strassl, Andreas and Kovacevic Miljevic, Katarina and Jilma, Bernd and Ay, Cihan and Königsbrügge, Oliver and Postula, Marek and Hengstenberg, Christian and Siller-Matula, Jolanta M},
title = {Prediction model for leaflet thrombosis in patients undergoing transcatheter aortic valve implantation: the EFFORT study},
journal = {Clinical Research in Cardiology},
year = {2025},
doi = {10.1007/s00392-024-02486-3}
}
EUVIMED